Clinical Proteomics

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical Proteomics is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,290 EUR. Declared review time at DOAJ: 17 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
1559-0275 · 1542-6416
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,290 EUR
Articles in DOAJ
125
Declared review time
17 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2011-06-23
  • PUBMED · 2006-03-01
Indexing
DOAJ · PUBMED
APC
2,290 EUR
Declared review time (DOAJ)
17 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

125

Most recent article

7 years ago

Average review time (journal-declared via DOAJ)

17weeks

Works in OpenAlex

769

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

57

i10-index

408

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2011-06-23
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
91%
ORCID iDs in current deposits
12%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
101184586
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Advanced Proteomics Techniques and Applications
  • Advanced Proteomics Techniques and Applications
  • Glycosylation and Glycoproteins Research
  • Glycosylation and Glycoproteins Research
  • Mass Spectrometry Techniques and Applications
  • Advanced Biosensing Techniques and Applications
  • Mass Spectrometry Techniques and Applications
  • Advanced Biosensing Techniques and Applications
Show all subjects (50)
  • Metabolomics and Mass Spectrometry Studies
  • Metabolomics and Mass Spectrometry Studies
  • Clusterin in disease pathology
  • Clusterin in disease pathology
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • S100 Proteins and Annexins
  • S100 Proteins and Annexins
  • Ferroptosis and cancer prognosis
  • Molecular Biology Techniques and Applications
  • Ferroptosis and cancer prognosis
  • Molecular Biology Techniques and Applications
  • Extracellular vesicles in disease
  • Extracellular vesicles in disease
  • Alzheimer's disease research and treatments
  • Chronic Kidney Disease and Diabetes
  • Galectins and Cancer Biology
  • Chronic Kidney Disease and Diabetes
  • Alzheimer's disease research and treatments
  • Galectins and Cancer Biology
  • Rheumatoid Arthritis Research and Therapies
  • Salivary Gland Disorders and Functions
  • Salivary Gland Disorders and Functions
  • Rheumatoid Arthritis Research and Therapies
  • Machine Learning in Bioinformatics
  • Machine Learning in Bioinformatics
  • Renal Diseases and Glomerulopathies
  • Renal Diseases and Glomerulopathies
  • vaccines and immunoinformatics approaches
  • vaccines and immunoinformatics approaches
  • Cancer, Hypoxia, and Metabolism
  • Peptidase Inhibition and Analysis
  • Proteoglycans and glycosaminoglycans research
  • Cancer, Hypoxia, and Metabolism
  • Peptidase Inhibition and Analysis
  • Proteoglycans and glycosaminoglycans research
  • Carbohydrate Chemistry and Synthesis
  • Carbohydrate Chemistry and Synthesis
  • Biosensors and Analytical Detection
  • Biosensors and Analytical Detection
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies

Keywords (DOAJ)

  • translational proteomics
  • molecular medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: